Skip to main content

Table 2 Serum concentrations of mesothelin and midkine

From: Midkine is a potential novel marker for malignant mesothelioma with different prognostic and diagnostic values from mesothelin

 

Mesothelin (nmol/L)

Median (min-max)

Midkine (pg/mL)

Median (min-max)

Malignant mesothelioma

1.50 (0.30-67.50)

656.04 (103.95-17,381.64)

Metastatic cancers to pleura

0.90 (0.10-9.70)

560.69 (103.95-35,742.24)

Benign asbestos pleurisy

0.85 (0.10-3.40)

538.06 (103.95-1217.00)

Benign pleural diseases

0.80 (0.30-67.50)

423.03 (106.25-37,459.76)

Pleural diseases other than malignant mesotheliomaa

0.80 (0.10-9.70)

423.03 (103.95-37,459.76)

  1. aPleural diseases other than malignant mesothelioma include metastatic cancers, benign asbestos pleurisy and benign pleural diseases